Zepp Health Q1 Revenue Jumps 33.8% to US$51.5M, Q2 Guide at US$63–68M
ZEPP•Zepp Health's Q1 2026 revenue rose to US$51.5 million, up 33.8% year over year, while gross margin expanded to 37.7% despite elevated memory costs and entry-level product refresh. Cash balances held near US$103.2 million, inventory declined to US$62.8 million, and Q2 revenue is guided at US$63–68 million (6–14% growth).
1. Zepp Health Q1 Financial Highlights
Zepp Health posted US$51.5 million in first-quarter revenue, marking a 33.8% year-over-year increase, with gross profit rising 35.3% to US$19.4 million. Gross margin expanded to 37.7% from 37.3%, driven by improved premium product mix despite higher memory component costs and seasonal entry-level refresh.
2. New Product Launches and Partnerships
The company launched five new wearables—Amazfit Balance 3, Balance Ultra, Bip Max, Cheetah 2 Pro and Cheetah 2 Ultra—targeting diverse user segments from entry-level to marathon and trail runners. Zepp also secured an exclusive three-year global wearable partnership extension with HYROX and added Olympian Rory Linkletter to its Amazfit Athletes roster.
3. Cash, Inventory and Q2 Outlook
As of March 31, cash and equivalents were US$103.2 million, nearly flat year-over-year, while inventory fell to US$62.8 million, reflecting tighter management. For Q2, management forecasts revenue between US$63 million and US$68 million, implying 6%–14% growth and underlining confidence in product demand and shipment timing.
